Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies-Reference-Cited by-同舟云学术

Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies

Published:2015-07-21 Issue:2 Volume:163 Page:127-134
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Uno Hajime¹,Wittes Janet¹,Fu Haoda¹,Solomon Scott D.¹,Claggett Brian¹,Tian Lu¹,Cai Tianxi¹,Pfeffer Marc A.¹,Evans Scott R.¹,Wei Lee-Jen¹

Affiliation:

1. From Dana Farber Cancer Institute, Brigham and Women's Hospital, and Harvard University, Boston, Massachusetts; Statistics Collaborative, Washington, DC; Eli Lilly and Company, Indianapolis, Indiana; and Stanford University School of Medicine, Palo Alto, California.

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nonconcurrent Controls in Platform Trials: Can We Borrow Their Concurrent Observation Data?;Statistics in Biopharmaceutical Research;2023-10-05

2. Challenges, Complexities, and Considerations in the Design and Interpretation of Late-Phase Oncology Trials;Seminars in Radiation Oncology;2023-10

3. Restricted mean survival time to estimate an intervention effect in a cluster randomized trial;Statistical Methods in Medical Research;2023-08-09

4. Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium;Journal of Clinical Oncology;2023-07-20

5. A comparison of different population-level summary measures for randomised trials with time-to-event outcomes, with a focus on non-inferiority trials;Clinical Trials;2023-06-20